Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Franklin Wharam, Mb.Bch,Bao

Co-Author

This page shows the publications co-authored by James Wharam and Alison Galbraith.
Connection Strength

2.833
  1. Controller Medication Use and Exacerbations for Children and Adults With Asthma in High-Deductible Health Plans. JAMA Pediatr. 2021 Aug 01; 175(8):807-816.
    View in: PubMed
    Score: 0.978
  2. Association of Controller Use and Exacerbations for High-Deductible Plan Enrollees with and without Family Members with Asthma. Ann Am Thorac Soc. 2021 07; 18(7):1255-1260.
    View in: PubMed
    Score: 0.972
  3. Out-of-Pocket Spending for Asthma-Related Care Among Commercially Insured Patients, 2004-2016. J Allergy Clin Immunol Pract. 2021 Sep 01.
    View in: PubMed
    Score: 0.246
  4. Costs Are Higher For Marketplace Members Who Enroll During Special Enrollment Periods Compared With Open Enrollment. Health Aff (Millwood). 2020 08; 39(8):1354-1361.
    View in: PubMed
    Score: 0.228
  5. Use of well-child visits in high-deductible health plans. Am J Manag Care. 2010 Nov; 16(11):833-40.
    View in: PubMed
    Score: 0.116
  6. High-deductible health plans: are vulnerable families enrolled? Pediatrics. 2009 Apr; 123(4):e589-94.
    View in: PubMed
    Score: 0.104
  7. Cancer screening before and after switching to a high-deductible health plan. Ann Intern Med. 2008 May 06; 148(9):647-55.
    View in: PubMed
    Score: 0.098
  8. Emergency department use and subsequent hospitalizations among members of a high-deductible health plan. JAMA. 2007 Mar 14; 297(10):1093-102.
    View in: PubMed
    Score: 0.090
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.